EstechPharma Co. Ltd (041910) — Cash Flow-to-Debt Ratio
EstechPharma Co. Ltd (041910) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of ₩2.38 Billion could theoretically repay 0% of its total liabilities (₩60.00 Billion) in one year. Explore 041910 strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
EstechPharma Co. Ltd Cash Flow-to-Debt Ratio (2013–2025)
Historical debt coverage capacity for EstechPharma Co. Ltd across 13 annual periods. Also explore EstechPharma Co. Ltd asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for EstechPharma Co. Ltd (2013–2025)
Year-by-year debt coverage analysis for EstechPharma Co. Ltd. For market capitalisation and broader financial context, see EstechPharma Co. Ltd stock valuation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.15x | ₩8.83 Billion | ₩60.00 Billion | ▼ -89.1% |
| 2024 | 1.35x | ₩7.93 Billion | ₩5.87 Billion | ▲ +76.9% |
| 2023 | 0.76x | ₩4.79 Billion | ₩6.27 Billion | ▲ +481.2% |
| 2022 | -0.20x | ₩-1.65 Billion | ₩8.23 Billion | ▼ -467.5% |
| 2021 | 0.05x | ₩603.42 Million | ₩11.06 Billion | ▼ -86.4% |
| 2020 | 0.40x | ₩4.71 Billion | ₩11.76 Billion | ▲ +28.0% |
| 2019 | 0.31x | ₩4.29 Billion | ₩13.71 Billion | ▼ -60.7% |
| 2018 | 0.80x | ₩7.25 Billion | ₩9.09 Billion | ▲ +43.4% |
| 2017 | 0.56x | ₩6.99 Billion | ₩12.57 Billion | ▲ +36.2% |
| 2016 | 0.41x | ₩8.19 Billion | ₩20.05 Billion | ▼ -24.9% |
| 2015 | 0.54x | ₩10.46 Billion | ₩19.24 Billion | ▲ +320.0% |
| 2014 | 0.13x | ₩4.99 Billion | ₩38.57 Billion | ▼ -53.7% |
| 2013 | 0.28x | ₩10.19 Billion | ₩36.41 Billion | — |